Pfizer Stock Quote Today

<div class='circular--portrait' style='background:#FF0F00;color: #FFFFF0;font-size:3em;padding-top: 38px;;'>PFE</div>
Pfizer is trading at 33.83 as of the 12th of July 2020, which is 1.08% increase since the beginning of the trading day. The stock's lowest day price was 33.49. Pfizer has about a 38 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 30 days. Equity ratings for Pfizer Inc are calculated daily based on the scoring framework. The performance scores are derived for the period starting the 13th of April 2020 and ending today, the 12th of July 2020. Click here to learn more.

   Performance
0 100 

   Odds of Distress
38  

Pfizer Profile

The upcoming quarterly report is expected on the 28th of July 2020. The stock experiences the above-average trading activities. Pfizer Inc. develops, manufactures, and sells healthcare products worldwide. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York. Pfizer operates under Drug ManufacturersGeneral classification in the United States and is traded on BATS Exchange. It employs 88300 people. more on Pfizer
Legal NamePfizer Inc
PresidentJohn YoungView All
Thematic Classifications
Active investing themes Pfizer currently participates. An investing theme is an unweighted collection of funds, stocks, ETFs or cryptocurrencies
Average Analyst Recommendation
Current trade recommendation based on an ongoing consensus estimate among financial analysis covering Pfizer Inc. The Pfizer consensus assessment is calculated by taking the average estimates from all of the analysts covering Pfizer
Piotroski F Score
Academic score (developed by Joseph Piotroski in 2002) to determine the current strength of Pfizer Inc financial position. Scores of 8 and 9 are usually clasified strong value stocks whereas scores of 2 or below are considered weak value stocks.
 5 - HealthyDetails
Current ValueLast YearChange From Last Year 10 Year Trend
Weighted Average Shares6.8 B5.6 B
Fairly Up
Decreasing
Slightly volatile
Weighted Average Shares Diluted6.9 B5.7 B
Fairly Up
Decreasing
Slightly volatile
Net Cash Flow from Operations15.8 B12.6 B
Significantly Up
Decreasing
Stable
Total Assets189.4 B167.5 B
Moderately Up
Decreasing
Slightly volatile
Total Liabilities114.4 B104.3 B
Significantly Up
Increasing
Stable
Current Assets46.2 B32.8 B
Significantly Up
Decreasing
Slightly volatile
Current Liabilities31.9 B37.3 B
Fairly Down
Increasing
Slightly volatile
Total Debt51.7 B52.1 B
Slightly Down
Increasing
Slightly volatile
Return on Average Assets8.289.9556
Significantly Down
Increasing
Slightly volatile
Gross Margin75.5580.2531
Notably Down
Decreasing
Very volatile
Asset Turnover0.350.3166
Significantly Up
Increasing
Very volatile
Macroaxis Advice
Macroaxis buy hold or sell recommendation provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of Pfizer available fundamental, technical, and predictive indicators. Current horizon is 30 days (very short) - details
Financial Strength
Pfizer financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Pfizer success along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
AA- ( Average Bond Rating ) Very Strong
  Operating Cash Flow
Pfizer Inc (PFE) is traded on BATS Exchange in USA and employs 88,300 people. The company currently falls under 'Mega-Cap' category with total capitalization of 185.86 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Pfizer's market, we take the total number of its shares issued and multiply it by Pfizer's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. Pfizer Inc runs under Healthcare sector within Drug Manufacturers?General industry. The entity has 5.55 B outstanding shares of which 53.75 M shares are at this time shorted by investors with about 1.75 days to cover shorted positions. PFIZER INC has about 10.36 B in cash with 14.02 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.87.
Check Pfizer Probability Of Bankruptcy

Ownership Allocation (%)

Pfizer Stock Price Odds Analysis

Odds Down 33.83HorizonTargetOdds Up 33.83
16.10%30 days
 33.83 
83.76%
Based on a normal probability distribution, the odds of Pfizer to move above the current price in 30 days from now is about 83.76 (This Pfizer Inc probability density function shows the probability of Pfizer Stock to fall within a particular range of prices over 30 days) .

Pfizer Stock Institutional Holders

InstituionSecurity TypeTotal SharesValue
Confluence Investment Management LlcCommon Shares2.3 M76.1 M
Park National CorpCommon Shares470.4 K15.4 M
View Pfizer Diagnostics

Pfizer Income Statement Over Time

Pfizer Inc Income Statement is one of the three primary financial statements used for reporting Pfizer's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Pfizer Inc revenue and expense. Pfizer Income Statement primarily focuses on the company's revenues and expenses during a particular period. Pfizer Net Income to Non Controlling Interests is expected to increase significantly based on the last few years of reporting. The past year's Net Income to Non Controlling Interests was at 29 Million. The current year Operating Income is expected to grow to about 12.4 B, whereas Cost of Revenue is expected to decline to about 9.9 B. View More Fundamentals

Pfizer Stock Against Markets

Did you try this?

Run Equity Analysis Now

   

Equity Analysis

Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
All  Next Launch Module

Pfizer Upcoming and Recent Events

Pfizer Company Earnings Announcements Dates

Upcoming Quarterly Report28th of July 2020
Next Earnings Report3rd of November 2020
Next Fiscal Quarter End30th of June 2020
Next Fiscal Year End26th of January 2021
Last Quarter Report31st of March 2020
Last Earning Announcement30th of June 2019

Pfizer Corporate Filings

Pfizer SEC Reporting

Financial Statements and Exhibits. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
View
Unclassified Corporate Event
View
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
View
Other Events
View

Pfizer Distributions to stockholders

A dividend is the distribution of a portion of Pfizer earnings, decided and managed by the Pfizers board of directors and paid to a class of its shareholders. Note, announcements of dividend payouts are generally accompanied by a proportional increase or decrease in a company's stock price. Pfizer dividend payments follow a chronological order of events, and the associated dates are important to determine the shareholders who qualify for receiving the dividend payment.
7th of May 2020
30th of January 2020
7th of November 2019
1st of August 2019
9th of May 2019
31st of January 2019
8th of November 2018
2nd of August 2018
Please check Your Equity Center. Please also try Equity Analysis module to research over 250,000 global equities including funds, stocks and etfs to find investment opportunities.
Company logos by clearbit
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page